GNRH1 and polycystic ovary syndrome: In an animal study, activation of GnRH neurons using designer receptors exclusively activated by designer drugs (DREADDs) resulted in neuroendocrine disturbances, including pathological hormone secretion and disrupted estrous cycles resembling PCOS.